-
We are thrilled to announce the achievements of our Department of Neurology Patient Experience Leaders! The Office of Patient Experience and Engagement has collected patient feedback over the past year and the results are remarkable—this has been an exceptional year for patient care satisfaction in the Department of Neurology. Their average care satisfaction score of 95% or higher (minimum of 30 ratings) in important areas such as active listening, demonstrating care and concern, providing clear[…]
-
Andrew Arrant, Ph.D. The American Parkinson Disease Association (APDA) has recently allocated $1.975 million to support groundbreaking research in the field of Parkinson's disease (PD) for the upcoming year, 2023-2024. APDA's research focus is steadfast, with an emphasis on identifying and supporting early-career researchers to encourage their dedication to PD research and aiding established investigators in pursuing innovative ideas. The research initiatives to be funded will explore various crucial aspects of PD biology, such as[…]
-
Migraine Awareness Week is September 24-30, 2023, and Emily Schiltz Fortenberry, M.D., assistant professor in the Department of Neurology, shared seven common migraine triggers to keep in mind.
-
The M.D./Ph.D. student has since moved on to clinical studies, but the research into possible drugs to treat Alzheimer’s disease continues.
-
While preventive treatment with vigabatrin delayed the onset and prevalence of infantile spasms in TSC infants, it had no impact on focal seizures, drug-resistant epilepsy, or improvement of cognitive and behavioral scores at 24 months.
-
Rachel Smith, Ph.D., professor in the UAB School of Engineering and principal investigator in the Neural Signal Processing and Modeling lab, was recently awarded multiple grants to fund research in seizure onset localization.
-
On August 19, 2023, the UAB Neurology team, known as "The Strokes," recently left a significant mark on the Dragon Boat Festival hosted by Mitchell’s Place Dragon Boats. This event brought teams together for a day of dragon boat racing, highlighting teamwork and athletic spirit. UAB Neurology team's participation underscored the fusion of medical expertise and collaborative sportsmanship. As an ancient Chinese tradition, dragon boat racing involves synchronized paddling to a rhythmic drumbeat. For "The[…]
-
On Thursday, Aug. 10, the UAB Medicine Leadership Development Office (LDO) held its first annual reception to honor the participants of six cohorts (91 graduates) who have completed the UAB Medicine Institute for Leadership.
-
TCE is a known environmental risk factor for parkinsonism. UAB researchers will evaluate whether T cell activation caused by TCE exposure leads to cognitive decline.
-
The University of Alabama at Birmingham's (UAB) Department of Neurology has achieved remarkable recognition in the latest U.S. News and World Report rankings. This prestigious acknowledgment solidifies UAB's standing as a frontrunner in world of neurological care. UAB Neurology’s high ranking is a result of is based on the analysis of various data categories, including patient outcomes such as patient survival, volume of high-risk patients, patient experience, nurse staffing and advanced clinical technologies. The recognition is[…]
-
Periodontal disease is one of the leading causes of tooth loss in adults and may be a risk factor in the development of Alzheimer’s disease.
-
The National Ataxia Foundation has named UAB a Center of Excellence. The designation is awarded to regional centers providing comprehensive care and services for individuals affected by ataxia and their families.
-
Ronald M. Lazar, Ph.D.In 2022, The University of Alabama at Birmingham launched a research pilot project called the Brain Health Advocacy Mission (BHAM), which provides brain health lifestyle strategies to patients at two UAB Family and Community Medicine Clinics. BHAM's primary objective is to develop individualized plans for preventing cognitive decline while encouraging study participants to make better choices in improving their brain health. “Brain Health successfully enrolled 100 patients from the UAB Highlands and[…]
-
In a mouse model, border-associated macrophages, not microglia, were essential for the neuroinflammation that precedes neurodegradation. Targeting this subset could be a disease-modifying therapy in neurodegenerative disease.
-
UAB scientist aims to inspire children from underrepresented backgrounds to pursue a career in science and help them understand that achieving their passions is possible.
-
Scott Marshall M.D. The University of Alabama at Birmingham (UAB) is thrilled to welcome its newest associate professor of Neurology, Scott A. Marshall Jr., M.D. Prior to joining UAB, Marshall's career has been marked by dedication and exemplary service. He served most recently as a Staff Neurointensivist and Vascular Neurologist at Intermountain Medical Center, part of Intermountain Health, in Murray, Utah. His tenure at Intermountain allowed him to treat diverse patient populations and refine his[…]
-
The UAB Comprehensive Stroke Center has been recertified by the Joint Commission. This designation identifies UAB as an industry leader responsible for setting the national agenda in highly specialized stroke care.
-
IN8bio has opened a new Birmingham facility, a 10,000-square-foot advanced research and development laboratory in the Martin Biscuit Building at Pepper Place.
-
The UAB Department of Neurology hosted the Neurology Research Lunch and Learn: Time Management on July 12, 2023, with guest speakers Jenna Smith, RN, BSN, manager of clinical research nursing, and Kellie Carter, Ph.D., senior leadership development specialist of UAB Health System. The speakers spoke on the benefit of effective time management and scheduling, the difference between importance and urgency, and more.
-
UAB was involved in clinical trials that led to an accelerated approval of the drug lecanemab, commercially known as Leqembi, in January 2023. A UAB Alzheimer’s expert discusses the therapy and what full approval means for the AD field.
